Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C23H28N2O5 |
| Molecular Weight | 412.4788 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOC1=C(OC)C=C2C(=C1)[C@H]3C[C@H](O)CC[C@H]3N=C2C4=CC=C(OC)N=C4OC
InChI
InChIKey=NQMAAFUKIUCXHK-MZMPZRCHSA-N
InChI=1S/C23H28N2O5/c1-5-30-20-11-15-16-10-13(26)6-8-18(16)24-22(17(15)12-19(20)27-2)14-7-9-21(28-3)25-23(14)29-4/h7,9,11-13,16,18,26H,5-6,8,10H2,1-4H3/t13-,16-,18-/m1/s1
| Molecular Formula | C23H28N2O5 |
| Molecular Weight | 412.4788 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 21:04:36 GMT 2025
by
admin
on
Wed Apr 02 21:04:36 GMT 2025
|
| Record UNII |
6C7UKU3FVA
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
864740-19-2
Created by
admin on Wed Apr 02 21:04:36 GMT 2025 , Edited by admin on Wed Apr 02 21:04:36 GMT 2025
|
PRIMARY | |||
|
6C7UKU3FVA
Created by
admin on Wed Apr 02 21:04:36 GMT 2025 , Edited by admin on Wed Apr 02 21:04:36 GMT 2025
|
PRIMARY | |||
|
11258441
Created by
admin on Wed Apr 02 21:04:36 GMT 2025 , Edited by admin on Wed Apr 02 21:04:36 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
TARGET -> INHIBITOR |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
Treatment and/or prophylaxis of non-alc. fatty liver disease (NAFLD).
|
